Sundi D, Collier K, Yang Y, Diaz D, Pohar K, Singer E
    
    
    Cancers (Basel). 2024; 16(4).
  
  
    PMID: 38398136
    
          PMC: 10886823.
    
          DOI: 10.3390/cancers16040746.
      
 
                                  
  
    Lee K, Kim B, Jeong S, Jeong C, Ku J, Kwak C
    
    
    Int J Mol Sci. 2020; 21(17).
  
  
    PMID: 32847068
    
          PMC: 7503698.
    
          DOI: 10.3390/ijms21176089.
      
 
                                  
  
    Lee K, Kim B, Jeong S, Jeong C, Ku J, Kim H
    
    
    Int J Mol Sci. 2020; 21(16).
  
  
    PMID: 32781788
    
          PMC: 7460860.
    
          DOI: 10.3390/ijms21165658.
      
 
                                  
  
    Ide H, Miyamoto H
    
    
    Cancers (Basel). 2020; 12(8).
  
  
    PMID: 32759680
    
          PMC: 7465876.
    
          DOI: 10.3390/cancers12082155.
      
 
                                  
  
    Hao K, Zhao S, Cui D, Zhang Y, Jiang C, Jing Y
    
    
    Int J Clin Exp Pathol. 2020; 10(7):7603-7615.
  
  
    PMID: 31966605
    
          PMC: 6965281.
    
      
 
                              
              
                              
                                      
  Role of androgen receptor expression in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
  
    Sanguedolce F, Cormio L, Carrieri G, Calo B, Russo D, Menin A
    
    
    Histol Histopathol. 2019; 35(5):423-432.
  
  
    PMID: 31803932
    
    
          DOI: 10.14670/HH-18-189.
      
 
                                          
                                                          
  The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer.
  
    Moschini M, Zaffuto E, Karakiewicz P, Mattei A, Gandaglia G, Fossati N
    
    
    World J Urol. 2018; 37(6):1127-1135.
  
  
    PMID: 30276543
    
    
          DOI: 10.1007/s00345-018-2504-3.
      
 
                                          
                                                          
  HOXB13 is not expressed in pleomorphic giant cell carcinoma of the bladder.
  
    Barresi V
    
    
    Virchows Arch. 2018; 473(2):259-260.
  
  
    PMID: 29926185
    
    
          DOI: 10.1007/s00428-018-2394-1.
      
 
                                          
                                                          
  Expression and clinical significance of androgen receptor in bladder cancer: A meta-analysis.
  
    Chen J, Cui Y, Li P, Liu L, Li C, Zu X
    
    
    Mol Clin Oncol. 2017; 7(5):919-927.
  
  
    PMID: 29181189
    
          PMC: 5700275.
    
          DOI: 10.3892/mco.2017.1389.
      
 
                                          
                                                          
  Androgen Receptor Signaling in Bladder Cancer.
  
    Li P, Chen J, Miyamoto H
    
    
    Cancers (Basel). 2017; 9(2).
  
  
    PMID: 28241422
    
          PMC: 5332943.
    
          DOI: 10.3390/cancers9020020.
      
 
                                          
                                                          
  AR-Signaling in Human Malignancies: Prostate Cancer and Beyond.
  
    Schweizer M, Yu E
    
    
    Cancers (Basel). 2017; 9(1).
  
  
    PMID: 28085048
    
          PMC: 5295778.
    
          DOI: 10.3390/cancers9010007.
      
 
                                          
                                                          
  Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression.
  
    Godoy G, Gakis G, Smith C, Fahmy O
    
    
    Bladder Cancer. 2016; 2(2):127-137.
  
  
    PMID: 27376135
    
          PMC: 4927898.
    
          DOI: 10.3233/BLC-160052.
      
 
                                          
                                                          
  Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals.
  
    Lin C, Lin W, Yeh S, Li L, Chang C
    
    
    Oncotarget. 2015; 6(40):43081-9.
  
  
    PMID: 26517808
    
          PMC: 4767492.
    
          DOI: 10.18632/oncotarget.5638.
      
 
                                          
                                                          
  Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.
  
    Garcia P, Apolinario L, Bockelmann P, da Silva Nunes I, Duran N, Favaro W
    
    
    Int J Clin Exp Pathol. 2015; 8(5):4427-43.
  
  
    PMID: 26191134
    
          PMC: 4503006.
    
      
 
                                          
                                                          
  Poor survival of females with bladder cancer is limited to those aged 70 years or over: a population-wide linkage study, New South Wales, Australia.
  
    Patel M, Bang A, Gillett D, Cheluvappa R, Smith D
    
    
    Cancer Med. 2015; 4(8):1145-52.
  
  
    PMID: 25914165
    
          PMC: 4559025.
    
          DOI: 10.1002/cam4.452.
      
 
                                          
                                                          
  Therapeutic effects of date fruits (Phoenix dactylifera) in the prevention of diseases via modulation of anti-inflammatory, anti-oxidant and anti-tumour activity.
  
    Rahmani A, Aly S, Ali H, Babiker A, Srikar S, Khan A
    
    
    Int J Clin Exp Med. 2014; 7(3):483-91.
  
  
    PMID: 24753740
    
          PMC: 3992385.
    
      
 
                                          
                                                          
  Implication of androgen receptor in urinary bladder cancer: a critical mini review.
  
    Rahmani A, Alzohairy M, Babiker A, Khan A, Aly S, Rizvi M
    
    
    Int J Mol Epidemiol Genet. 2013; 4(3):150-5.
  
  
    PMID: 24046807
    
          PMC: 3773566.
    
      
 
                                          
                                                          
  Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
  
    Hsu J, Hsu I, Xu D, Miyamoto H, Liang L, Wu X
    
    
    Am J Pathol. 2013; 182(5):1811-20.
  
  
    PMID: 23499463
    
          PMC: 3644728.
    
          DOI: 10.1016/j.ajpath.2013.01.018.
      
 
                                          
                                                          
  Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder.
  
    Kluth L, Fajkovic H, Xylinas E, Crivelli J, Passoni N, Roupret M
    
    
    World J Urol. 2012; 31(5):1029-36.
  
  
    PMID: 23196773
    
    
          DOI: 10.1007/s00345-012-0996-9.
      
 
                                          
                                                          
  Impact of gender on bladder cancer incidence, staging, and prognosis.
  
    Fajkovic H, Halpern J, Cha E, Bahadori A, Chromecki T, Karakiewicz P
    
    
    World J Urol. 2011; 29(4):457-63.
  
  
    PMID: 21656173
    
    
          DOI: 10.1007/s00345-011-0709-9.